Sign In
Get Clay Free →

Suggestions

    Julien Daubriac

    Senior Scientist, Disease Biology

    Julien Daubriac is a Senior Scientist at Exscientia, a company specializing in artificial intelligence-driven drug discovery. He has a robust background in cancer biology and pharmacology, accumulating over 15 years of experience in the field. Prior to his current role at Exscientia, he held significant positions at Recursion Pharmaceuticals and Oncodesign, contributing to advancements in drug development and cancer research.

    Daubriac's academic credentials include education from Université Denis Diderot (Paris VII), where he focused on cellular pharmacology. His research has led to numerous publications, indicating a strong commitment to advancing scientific knowledge in oncology and therapeutic strategies.

    At Exscientia, Daubriac is involved in projects that leverage AI to optimize the drug discovery process, aiming to improve the efficiency and effectiveness of developing new treatments for various diseases, particularly cancer. His work aligns with the growing trend of integrating technology into biomedical research to accelerate the creation of novel therapeutics.

    Highlights

    USP7 inhibitors suppress tumour neoangiogenesis and promote ...
    Apr 11 · pure.qub.ac.uk
    USP7 inhibitors suppress tumour neoangiogenesis and promote ...

    Related Questions

    What are Julien Daubriac's main research interests at Exscientia?
    How has Julien Daubriac contributed to the field of oncology?
    What projects is Julien Daubriac currently working on at Exscientia?
    Can you provide examples of Julien Daubriac's publications or research papers?
    What is Julien Daubriac's educational background?
    Julien Daubriac
    Julien Daubriac, photo 1
    Julien Daubriac, photo 2
    Add to my network

    Location

    Oxford, England, United Kingdom